Specificity, polyspecificity, and heterospecificity of antibody-antigen recognition

Journal of Molecular Recognition

Volumn 27, Issue 11, 2014, Pages 627-639

  Van Regenmortel, Marc H V ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

antibody specificity; epitope prediction; heterospecificity; HIV 1 vaccines; monogamous bivalent binding; peptide hydropathic complementarity; polyreactive antibodies; polyspecificity

Indexed keywords

ANTIBODY; ANTIGEN ANTIBODY COMPLEX; COMPLEMENTARITY DETERMINING REGION;

ANIMAL; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; CHEMISTRY; COMPLEMENTARITY DETERMINING REGION; HUMAN; IMMUNOLOGY;

ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; ANTIGEN-ANTIBODY COMPLEX; COMPLEMENTARITY DETERMINING REGIONS; HUMANS;

EID: 84907940987     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.2394     Document Type: Article

References (144)

1. Vyas JM, Van der Veen AG, Ploegh HL,. 2008. The known unknowns of antigen processing and presentation. Nat. Rev. Immunol. 8: 607-618.
2. Mc Lennan IC,. 1994. Germinal centers. Ann. Rev. Immunol. 12: 117-139.
3. Rajewsky K,. 1996. Clonal selection and learning in the antibody system. Nature 381: 751-758.
4. Tarlinton DM, Smith KG,. 2000. Dissecting affinity maturation: a model explaining selection of antibody-forming cells and memory B cells in the germinal centre. Immunol. Today 21: 436-441.
5. Wabl M, Cascalho M, Steinberg C,. 1999. Hypermutation in antibody affinity maturation. Curr. Opin. Immunol. 11: 186-189.
6. Zotos D, Tarlington DM,. 2012. Determining germinal centre B cell fate. Trends Immunol. 33: 281-288.
7. Bhattacharjee AK, Glaudemans CP,. 1978. Dual binding specificities in MOPC 384 and 870 murine myeloma immunoglobulins. J. Immunol. 120: 411-413.
8. Mayr E,. 1982. The growth of biological thought. Diversity, evolution, and inheritance. Harvard University Press: Cambridge, Mass; 974.
9. Mazumdar PH,. 1995. Species and specificity. Cambridge University Press: Cambridge.
10. Landsteiner K,. 1962. The specificity of serological reactions. Dover Publications: New York; 330.
11. Silverstein AM,. 1982. History of immunology: development of the concept of immunologic specificity: II. Cell. Immunol. 71: 183-195.
12. Sundberg EJ, Mariuzza RA,. 2002. Molecular recognition in antibody-antigen complexes. Adv. Protein Chem. 61: 119-160.
13. Van Regenmortel MHV,. 1998. From absolute to exquisite specificity. Reflections on the fuzzy nature of species, specificity and antigenic sites. J. Immunol. Meth. 216: 37-48.
14. Berzofsky JA, Schechter AN,. 1981. The concepts of crossreactivity and specificity in immunology. Mol. Immunol. 18: 751-753.
15. Marchalonis JJ, Kaveri S, Lacroix-Desmazes S, Kazatchkine MD,. 2002. Natural recognition repertoire and the evolutionary emergence of the combinatorial immune system. FASEB J. 16: 842-848.
16. Stewart J,. 1992. Immunoglobulins did not arise in evolution to fight infection. Immunol. Today 13: 396-399.
17. Cohn M,. 1997. A new concept of immune specificity emerges from a consideration of the self-nonself discrimination. Cell. Immunol. 181: 103-108.
18. Langman RE,. 2000. The specificity of immunological reactions. Mol. Immunol. 37: 555-561.
19. Efroni S, Cohen IR,. 2002. Simplicity belies a complex system: a response to the minimal model of immunity of Langman and Cohn. Cell. Immunol. 216: 23-30.
20. Gonzalez S, González-Rodríguez AP, Suárez-Álvarez B, Lõpez-Soto A, Huergo-Zapico L, Lopez-Larrea C,. 2011. Conceptual aspects of self and nonself discrimination. Self Nonself 2: 19-25.
21. Schroer JA, Bender T, Feldmann T, Kim KJ,. 1983. Mapping epitopes on the insulin molecule using monoclonal antibodies. Eur. J. Immunol. 13: 693-700.
22. Edwards BM, Barash SC, Main SH, Choi GH, Minter R, Ullrich S, Williams E, Du Fou L, Wilton J, Albert VR, Ruben SM, Vaughan TJ,. 2003. The remarkable flexibility of the human antibody repertoire, isolation of over one thousand different antibodies to a single protein. BLyS. J. Mol. Biol. 334: 103-118.
23. Cohn M,. 2005. Degeneracy, mimicry and cross-reactivity in immune recognition. Mol. Immunol. 42: 651-655.
24. Sivalingam GN, Sheperd AJ,. 2012. An analysis of B-cell epitope discontinuity. Mol. Immunol. 51: 304-309.
25. Timmerman P, Puijk WC, Meloen RH,. 2007. Functional reconstruction and synthetic mimicry of a conformational epitope using CLIPS technology. J. Mol. Recognit. 20: 283-299.
26. Van Regenmortel MHV,. 2009. Synthetic peptide vaccines and the search for neutralization B cell epitopes. Open Vaccine J. 2: 33-44.
27. Chen S-WW, Van Regenmortel MHV, Pellequer J-L,. 2009. Structure activity relationships in peptide-antibody complexes: implications for epitope prediction and development of synthetic peptide vaccines. Curr. Med. Chem. 16: 953-964.
28. Van Regenmortel MHV,. 1998. Mimotopes, continuous paratopes and hydropathic complementarity: novel approximations in the description of immunochemical specificity. J. Dispers. Sci. Techn. 19: 1199-1219.
29. Laune D, Molina F, Ferrieres G, Mani JC, Cohen P, Simon D, Bernardi T, Piechaczyk M, Pau B, Granier C,. 1997. Systematic exploration of the antigen binding activity of synthetic peptides isolated from the variable regions of immunoglobulins. J. Biol. Chem. 272: 30937-30944.
30. Sällberg M, Sherefa K, Zhang ZX,. 1994. The antigen/antibody specificity exchanger: a new peptide based tool for re-directing antibodies of other specificities to recognize the V3 domain of HIV-1 gp120. Biochem. Biophys. Res. Commun. 205: 1386-1390.
31. Markus G, Tritsch GL, Parthasarathy R,. 1989. A model for hydropathy-based peptide interactions. Arch. Biochem. Biophys. 272: 433-439.
32. Tropsha A, Kizer JS, Chaiken IM,. 1992. Making sense from antisense: a review of experimental data and developing ideas on sense - antisense peptide recognition. J. Mol. Recognit. 5: 43-54.
33. Blalock JE, Bost KL,. 1986. Binding of peptides that are specified by complementary RNAs. Biochem. J. 234: 679-689.
34. Brentani RR,. 1988. Biological implications of complementary hydropathy of amino acids. J. Theor. Biol. 135: 495-499.
35. Biro JC,. 2005. Seven fundamental, unsolved questions in molecular biology. Cooperative storage and bi-directional transfer of biological information by nucleic acids and proteins: an alternative to "central dogma". Med. Hypotheses 63: 951-962.
36. Biro JC,. 2007. The Proteomic Code: a molecular recognition code for proteins. Theor. Biol. Med. Model. 4: 45.
37. Achour A, Biquard JM, Krsmanovic V, M'bika JP, Ficheux D, Sikorska M, Cozzone AJ,. 2007. Induction of human immunodeficiency virus (HIV-1) envelope specific cell-mediated immunity by a non-homologous synthetic peptide. PLoS One 2 (11): e1214.
38. Benjamin DC, Berzofsky JA, East IJ, Gurd FRN, Hannum C, Leach SJ, Margoliash E, Michael JG, Miller A, Prager EM, Reichlin M, Sercaz EE, Smith-Gill SJ, Todd PE, Wilson AC,. 1984. The antigenic structure of proteins: a reappraisal. Ann. Rev. Immunol. 2: 67-101.
39. Berzofsky JA,. 1985. Intrinsic and extrinsic factors in protein antigenic structure. Science 229: 932-940.
40. Getzoff ED, Tainer JA, Lerner RA, Geysen HM,. 1988. The chemistry and mechanism of antibody binding to protein antigens. Adv. Immunol. 43: 1-98.
41. Van Regenmortel MHV,. 1999. Molecular dissection of protein antigens and the prediction of epitopes. In Synthetic peptides as antigens, Van Regenmortel MHV, Muller S, (eds). Elsevier: Amsterdam; 1-78.
42. Padlan EA, Abergel C, Tipper JP,. 1995. Identification of specificity-determining residues in antibodies. FASEB J. 9: 133-139.
43. MacCallum RM, Martin AC, Thornton JM,. 1996. Antibody-antigen interactions: contact analysis and binding site topography. J. Mol. Biol. 262: 732-745.
44. Raghunathan G, Smart J, Williams J, Almagro JC,. 2012. Antigen-binding site anatomy and somatic mutations in antibodies that recognize different types of antigens. J. Mol. Recognit. 25: 103-113.
45. Wu TT, Kabat EA,. 1970. An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J. Exp. Med. 132: 211-250.
46. Chothia C, Lesk AM,. 1987. Canonical structures for the hypervariable regions of immunoglobulins. J. Mol. Biol. 196: 901-917.
47. Almagro JC,. 2004. Identification of differences in the specificity-determining residues of antibodies that recognize antigens of different size: implications for the rational design of antibody repertoires. J. Mol. Recognit. 17: 132-143.
48. Lefranc MP,. 2003. IMGT, the international ImMunoGeneTics database. Nucl. Acid Res. 31: 307-310.
49. Lefranc MP, Giudicelli V, Kaas Q, Duprat E, Jabado-Michaloud J, Scaviner D, Ginestoux C, Clément O, Chaume D, Lefranc G,. 2005. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res. 33: D593-597.
50. Kunik V, Ashkenazi S, Ofran Y,. 2012a. Paratome: an online tool for systematic identification of antigen-binding regions in antibodies based on sequence or structure. Nucleic Acids Res. 40: W521-524.
51. Kunik V, Peters B, Ofran Y,. 2012b. Structural consensus among antibodies defines the antigen binding site. PLoS Comput. Biol. 8: e1002388.
52. Sela-Culang I, Kunik V, Ofran Y,. 2013. The structural basis of antibody-antigen recognition. Front. Immunol. 4: 302. Doi: 10.3389/fimmu.2013:00302
53. Kunik V, Ofran Y,. 2013. The indistinguishability of epitopes from protein surface is explained by the distinct binding preferences of each of the six antigen-binding loops. Protein Eng. Des. Sel. 26: 599-609.
54. Collis AV, Brouwer AP, Martin AC,. 2003. Analysis of the antigen combining site: correlations between length and sequence composition of the hypervariable loops and the nature of the antigen. J. Mol. Biol. 325: 337-354.
55. North B, Lehmann A, Dunbrack RL Jr,. 2011. A new clustering of antibody CDR loop conformations. J. Mol. Biol. 406: 228-256.
56. Kringelum JV, Nielsen M, Padkjær SB, Lund O,. 2013. Structural analysis of B-cell epitopes in antibody: protein complexes. Mol. Immunol. 53: 24-34.
57. Rubinstein ND, Mayrose I, Halperin D, Yekutieli D, Gershoni, JM, Pupko T,. 2008. Computational characterization of B-cell epitopes. Mol. Immunol. 45: 3477-3489.
58. Soga S, Kuroda D, Shirai H, Kobori M, Hirayama N,. 2010. Use of amino acid composition to predict epitope residues of individual antibodies. Protein Eng. Des. Sel. 23: 441-448.
59. Ofran Y, Schlessinger A, Rost B,. 2008. Automated identification of complementarity determining regions (CDRs) reveals peculiar characteristics of CDRs and B cell epitopes. J. Immunol. 181: 6230-6235.
60. Keskin O, Gursoy A, Ma B, Nussinov R,. 2008. Principles of protein-protein interactions: what are the preferred ways for proteins to interact? Chem. Rev. 108: 1225-1244.
61. Sela-Culang I, Benhnia MR, Matho MH, Kaever T, Maybeno M, Schlossman A, Nimrod G, Li S, Xiang Y, Zajonc D, Crotty S, Ofran Y, Peters B,. 2014. Using a combined computational-experimental approach to predict antibody-specific B cell epitopes. Structure. Doi: 10.1016/j.str.2014.02.003
62. Hopp TP, Woods KR,. 1981. Prediction of protein antigenic determinants from amino acid sequences. Proc. Natl. Acad. Sci. U. S. A. 78: 3824-3828.
63. Thornton JM, Edwards MS, Taylor WR, Barlow DJ,. 1986. Location of "continuous" antigenic determinants in the protruding regions of proteins. EMBO J. 5: 409-413.
64. Pellequer JL, Westhof E, Van Regenmortel MHV,. 1991. Predicting the location of continuous epitopes in proteins from their primary structures. Methods Enzymol. 203: 176-201.
65. Blythe MJ, Flower DR,. 2005. Benchmarking B cell epitope prediction: Underperformance of existing methods. Protein Sci. 14: 246-248.
66. Greenbaum JA, Andersen PH, Blythe M, Bui HH, Cachau RE, Crowe J, Davies M, Kolaskar AS, Lund O, Morrison S, Mumey B, Ofran Y, Pellequer JL, Pinilla C, Ponomarenko JV, Raghava GP, van Regenmortel MH, Roggen EL, Sette A, Schlessinger A, Sollner J, Zand M, Peters B,. 2007. Towards a consensus on datasets and evaluation metrics for developing B-cell epitope prediction tools. J. Mol. Recognit. 20: 75-82.
67. Liang S, Zheng D, Zhang C, Zacharias M,. 2009. Prediction of antigenic epitopes on protein surfaces by consensus scoring. BMC Bioinformatics 10: 302.
68. El-Manzalawy Y, Honavar V,. 2010. Recent advances in B cell epitope prediction methods. Immune Res. (Suppl 2). Doi: 10.1186/1745-7580-6-S2-S2
69. Zhang W, Xiong Y, Zhao M, Zou H, Ye X, Liu J,. 2011. Prediction of conformational B-cell epitopes from 3D structure by random forests with a distant-based feature. BMC Bioinformatics 12: 341.
70. Ponomarenko JV, Van Regenmortel MHV,. 2009. B cell epitope prediction. In Structural bioinformatics (2nd edn), Gu J, Bourne PE, (eds). John Wiley: Hoboken, NJ; 849-879.
71. Hopp TP,. 1993. Retrospective: 12 years of antigenic determinant predictions, and more. Pept. Res. 6: 183-190.
72. Gomara MJ, Haro I,. 2007. Synthetic peptides for the immunodiagnosis of human diseases. Curr. Med. Chem. 14: 531-546.
73. Muller S,. 1999. Use of antipeptide antibodies in molecular and cellular biology. In Synthetic peptides and antigens, Van Regenmortel MHV, Muller S, (eds). Elsevier Asterdam: The Netherlands; 215-235.
74. Chen J, Liu H, Yang J, Chou KC,. 2007. Prediction of linear B cell epitope using amino acid pair antigenicity scale. Amino Acids 33: 423-428.
75. Yao B, Zhang L, Liang S, Zhang C,. 2012. SVMTriP: a method to predict antigenic epitopes using support vector machine to integrate tri-peptide similarity and propensity. PLoS One 7: e45152.
76. Hans D, Young PR, Fairlie DP,. 2006. Current status of short synthetic peptides as vaccines. Med. Chem. 2: 627-646.
77. Van Regenmortel MHV,. 2006. Immunoinformatics may lead to a reappraisal of the nature of B cell epitopes and of the feasibility of synthetic peptide vaccines. J. Mol. Recognit. 19: 183-187.
78. Van Regenmortel MHV, Pellequer J-L,. 1994. Predicting antigenic determinants in proteins: looking for unidimensional solutions to a three-dimensional problem? Pept. Res. 7: 224-228.
79. Eisen HN, Chakraborty AK,. 2010. Evolving concepts of specificity in immune reactions. Proc. Natl. Acad. Sci. U. S. A. 107: 22373-22380.
80. Van Regenmortel MHV,. 2012. Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine. Arch. Virol. 157: 1-20.
81. Sperling R, Francus T, Siskind GW,. 1983. Degeneracy of antibody specificity. J. Immunol. 131: 882-885.
82. Cohen IR, Hershberg U, Solomon S,. 2004. Antigen-receptor degeneracy and immunological paradigms. Mol. Immunol. 40: 993-996.
83. Parnes O,. 2004. From interception to incorporation: degeneracy and promiscuous recognition as precursors of a paradigm shift in immunology. Mol. Immunol. 40: 985-991.
84. Sercarz EE, Maverakis E,. 2004. Recognition and function in a degenerate immune system. Mol. Immunol. 40: 1003-1108.
85. Zhou ZH, Tzioufas AG, Notkins AL,. 2007. Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells. J. Autoimmunity 29: 219-228.
86. Dimitrov JD, Planchais C, Roumenina LT, Vassilev TL, Kaveri SV, Lacroix-Desmazes S,. 2013. Antibody polyreactivity in health and disease: statu variabilis. J. Immunol. 191: 993-999.
87. Wucherpfennig KW, Allen PM, Celada F, Cohen IR, De Boer R, Garcia KC, Goldstein B, Greenspan R, Hafler D, Hodgkin P, Huseby ES, Krakauer DC, Nemazee D, Perelson AS, Pinilla C, Strong RK, Sercarz EE,. 2007. Polyspecificity of T cell and B cell receptor recognition. Semin. Immunol. 19: 216-224.
88. Van Regenmortel MHV,. 1989. The concept and operational definition of protein epitopes. Phil. Trans. Royal Soc. London B323: 451-466.
89. Chen ZJ, Wheeler CJ, Shi W, Wu AJ, Yarboro CH, Gallagher M, Notkins AL,. 1998. Polyreactive antigen-binding B cells are the predominant cell type in the newborn B cell repertoire. Eur. J. Immunol. 28: 989-994.
90. Zhou ZH, Zhang Y, Hu YF, Wahl LM, Cisar JO, Notkins AL,. 2007. The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies. Cell Host Microbe 1: 51-61.
91. Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC,. 2003. Predominant autoantibody production by early human B cell precursors. Science 301: 1374-1377.
92. Notkins AL,. 2004. Polyreactivity of antibody molecules. Trends Immunol. 25: 174-179.
93. Berek C, Miltstein C,. 1987. Mutation drift and repertoire shift in the maturation of the immune response. Immunol. Rev. 96: 23-41.
94. Wedemayer GJ, Patten PA, Wang LH, Schultz PG, Stevens RC,. 1997. Structural insights into the evolution of an antibody combining site. Science 276: 1665-1669.
95. Manivel V, Bayiroglu F, Siddiqui Z, Salunke DM, Rao KV,. 2002. The primary antibody repertoire represents a linked network of degenerate antigen specificities. J. Immunol. 169: 888-897.
96. Yin J, Beuscher AE, Andryski SE, Stevens RC, Schultz PG,. 2003. Structural plasticity and the evolution of antibody affinity and specificity. J. Mol. Biol. 330: 651-656.
97. Foote J, Eisen HN,. 1995. Kinetic and affinity limits on antibodies produced during immune responses. Proc. Natl. Acad. Sci. U. S. A. 92: 1254-1256.
98. Batista FD, Neuberger MS,. 1998. Affinity dependence of the B cell response to antigen: a threshold, a ceiling, and the importance of off-rate. Immunity 8: 751-759.
99. Mariuzza RA,. 2006. Multiple paths to multispecificity. Immunity 24: 359-361.
100. Sethi DK, Agarwal A, Manivel V, Rao KV, Salunke DM,. 2006. Differential epitope positioning within the germline antibody paratope enhances promiscuity in the primary immune response. Immunity 24: 429-438.
101. Mc Farland BJ, Strong RK,. 2003. Thermodynamic analysis of degenerate recognition by the NKG2D immunoreceptor: not induced fit but rigid adaptation. Immunity 19: 803-812.
102. James LC, Roversi P, Tawfik DS,. 2003. Antibody multi-specificity mediated by conformational diversity. Science 299: 1362-1367.
103. Khan T, Salunke DM,. 2012. Structural elucidation of the mechanistic basis of degeneracy in the primary humoral response. J. Immunol. 188: 1819-1827.
104. Jimenez R, Salazar G, Baldridge KK, Romesberg FE,. 2003. Flexibility and molecular recognition in the immune system. Proc. Natl. Acad. Sci. U. S. A. 100: 92-97.
105. Thorpe IF, Brooks CL 3rd,. 2007. Molecular evolution of affinity and flexibility in the immune system. Proc. Natl. Acad. Sci. U. S. A. 104: 8821-8826.
106. Richards FF, Konigsberg WH, Rosenstein RW, Varga JM,. 1975. On the specificity of antibodies. Science 187: 130-137.
107. Talmage DW,. 1959. Immunological specificity, unique combinations of selected natural globulins provide an alternative to the classical concept. Science 129: 1643-1648.
108. Schubert W, Bonnekoh B, Pommer AJ, Philipsen L, Böckelmann R, Malykh Y, Gollnick H, Friedenberger M, Bode M, Dress AWM,. 2006. Analyzing proteome topology and function by automated multi-dimensional fluorescence microscopy. Nat. Biotechnol. 24: 1270-1278.
109. Schubert W,. 2014. Systematic, spatial imaging of large multimolecular assemblies and the emerging principles of supramolecular order in biological systems. J. Mol. Recognit. 27: 3-18.
110. McMahon MJ, O'Kennedy R,. 2000. Polyreactivity as an acquired artefact, rather than a physiologic property, of antibodies: evidence that monoreactive antibodies may gain the ability to bind to multiple antigens after exposure to low pH. J. Immunol. Meth. 241: 1-10.
111. Bouvet JP, Stahl D, Rose S, Quan CP, Kazatchkine MD, Kaveri SV,. 2001. Induction of natural autoantibody activity following treatment of human immunoglobulin with dissociating agents. J Autoimmunity 16: 163-72.
112. Dimitrov JD, Planchais C, Kang J, Pashov A, Vassilev TL, Kaveri SV, Lacroix-Desmazes S,. 2010. Heterogeneous antigen recognition behavior of induced polyspecific antibodies. Biochem. Biophys. Res. Commun. 398: 266-271.
113. Van Regenmortel MHV,. 2012. Basic research in HIV vaccinology is hampered by reductionist thinking. Front. Immunol. 3: 194.
114. Oppezzo P, Dumas G, Bouvet JP, Robello C, Cayota A, Pizarro JC, Dighiero G, Pritsch O,. 2004. Somatic mutations can lead to a loss of superantigenic and polyreactive binding. Eur. J. Immunol. 34: 1423-1432.
115. Ditzel HJ, Itoh K, Burton DR,. 1996. Determinants of polyreactivity in a large panel of recombinant human antibodies from HIV-1 infection. J. Immunol. 157: 739-749.
116. Hunziker L, Recher M, Macpherson AJ, Ciurea A, Freigang S, Hengartner H, Zinkernagel RM,. 2003. Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections. Nat. Immunol. 4: 343-349.
117. Ludewig B, Krebs P, Metters H, Tatzel J, Türeci O, Sahin U,. 2004. Molecular characterization of virus-induced autoantibody responses. J. Exp. Med. 200: 637-646.
118. Haynes BF, Moody MA, Verkoczy L, Kelsoe G, Alam SM,. 2005. Antibody polyspecificity and neutralization of HIV-1: a hypothesis. Hum. Antibodies 14: 59-67.
119. Mouquet H, Scheid JF, Zoller MJ, Krogsgaard M, Ott RG, Shukair S, Artyomov MN, Pietzsch J, Connors M, Pereyra F, Walker BD, Ho DD, Wilson PC, Seaman MS, Eisen HN, Chakraborty AK, Hope TJ, Ravetch JV, Wardemann H, Nussenzweig MC,. 2010. Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation. Nature 467: 591-595.
120. Day ED,. 1990. Advanced immunochemistry (2nd edn). Wiley-Liss: New-York.
121. Zhu P, Liu J, Bess J Jr, Chertova E, Lifson JD, Grisé H, Ofek GA, Taylor KA, Roux KH,. 2006. Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature 441: 847-852.
122. Klein JS, Bjorkman PJ,. 2010. Few and far between: how HIV may be evading antibody avidity. PLoS athog. 6: e1000908.
123. Mouquet H, Nussenzweig MC,. 2012. Polyreactive antibodies in adaptive immune responses to viruses. Cell. Mol. Life Sci. 69: 1435-1445.
124. Van Regenmortel MHV, Hardie G,. 1976. Immunochemical studies of tobacco mosaic virus - II. Univalent and monogamous bivalent binding of IgG antibody. Immunochemistry 13: 503-507.
125. Klein JS, Gnanapragasam PN, Galimidi RP, Foglesong CP, West AP Jr, Bjorkman PJ,. 2009. Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10. Proc. Natl. Acad. Sci. U. S. A. 106: 7385-7390.
126. Ochsenbein AF, Fehr T, Lutz C, Suter M, Brombacher F, Hengartner H, Zinkernagel RM,. 1999. Control of early viral and bacterial distribution and disease by natural antibodies. Science 286: 2156-2159.
127. Münz C, Lünemann JD, Getts MT, Miller SD,. 2009. Antiviral immune responses: triggers of or triggered by autoimmunity? Nat. Rev. Immunol. 9: 246-258.
128. Mäkelä O,. 1965. Single lymph node cells producing heteroclitic bacteriophage antibody. J. Immunol. 95: 378-386.
129. Underwood PA,. 1985. Theoretical considerations of the ability of monoclonal antibodies to detect antigenic differences between closely related variants, with particular reference to heterospecific reactions. J. Immunol. Methods 85: 295-307.
130. Van Regenmortel MHV,. 1982. Serology and immunochemistry of plant viruses. Academic Press: New-York.; 268.
131. Von Sengbusch P, Wittman HG,. 1965. Serological and physicochemical properties of the wild strain and two mutants of tobacco mosaic virus with the same amino acid exchange in different positions of the protein chain. Biochem. Biophys. Res. Comm. 18: 780-787.
132. Loor F,. 1971. On the existence of heterospecific antibodies in sera from rabbits immunized against tobacco mosaic virus determinants. Immunology 21: 557-564.
133. Li X, Song B, Chen X, Wang Z, Zeng M, Yu D, Hu D, Chen Z, Jin L, Yang S, Yang C, Chen B,. 2013. Crystal structure of a four-layer aggregate of engineered TMV CP implies the importance of terminal residues for oligomer assembly. PLoS One 8: e77717.
134. Van Regenmortel MHV,. 1967. Serological studies on naturally occurring strains and chemically induced mutants of tobacco mosaic virus. Virology 31: 467-480.
135. Al Moudallal Z, Briand JP, Van Regenmortel MHV,. 1982. Monoclonal antibodies as probes of the antigenic structure of tobacco mosaic virus. EMBO J. 1: 1005-1010.
136. Boyd WC, Bernard H,. 1937. Quantitative changes in antibodies and globulin fractions in sera of rabbits injected with several antigens. J. Immunol. 33: 111-122.
137. Urbain-Vansanten G,. 1970. Concomitant synthesis, in separate cells, of non-reactive immunoglobulins and specific antibodies after immunization with tobacco mosaic virus. Immunology 19: 783-97.
138. De Vos-Cloetens C, Minsart-Baleriaux V, Urbain-Vansanten G,. 1971. Possible relationships between antibodies and non-specific immunoglobulins simultaneously induced after antigenic stimulation. Immunology 20: 955-958.
139. Eisen HN,. 2001. Specificity and degeneracy in antigen recognition: Yin and Yang in the immune system. Ann. Rev. Immunol. 19: 1-21.
140. Moticka EJ,. 1974. The non-specific stimulation of immunoglobulin secretion following specific stimulation of the immune system. Immunology 27: 401-412.
141. Haimovich J, Tarrab R, Sulica A, Sela M,. 1970. Antibodies of different specificities in normal rabbit sera. J. Immunol. 104: 1033-1034.
142. Frison EA, Stace-Smith R,. 1992. Cross-reacting and heterospecific monoclonal antibodies produced against arabis mosaic nepovirus. J. Gen. Virol. 73: 2525-2530.
143. Van Regenmortel MHV, Andrieu J-M, Dimitrov DS, Ensoli B, Hioe CE, Moog C, Ruprecht RM,. 2014. Paradigm changes and the future of HIV vaccine research: a summary of a workshop held in Baltimore on 20 November 2013. J. AIDS Clin. Res. 5: 3-8.
144. Coutinho A, Kazatchkine MD, Avrameas S,. 1995. Natural autoantibodies. Curr. Opin. Immunol. 7: 812-818.